Drug · DIN 02500833
QINLOCK
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 10, 2020; first marketed December 10, 2020.
- Drug Identification Number (DIN)
- 02500833
- Company (DIN owner)
- Deciphera Pharmaceuticals. LlcWaltham, Massachusetts, United States
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ripretinib L01EX19
- Class
- Human
- Record last updated
- January 9, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIPRETINIB | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 19, 2020: NOC 23819New Drug Submission (NDS)